Ensoma vs Thymmune Therapeutics
Thymmune Therapeutics
Biotech firm developing thymic cell therapies to restore immune function using machine learning
26 employees · est. 2019 · Cambridge, United States
Ensoma is the larger of the two.
Side-by-Side Comparison
| Metric | Ensoma | Thymmune Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2019 |
| Headquarters | ||
| Headquarters | Boston, United States | Cambridge, United States |
| Employees | ||
| Employees | 51 larger | 26 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Seed |
| Total Funding | ||
| Total Funding | $258.00M | $44.30M |
| Funding Rounds | ||
| Funding Rounds | 5 | 3 |
| Services | ||
| Services | In Vivo Hematopoietic Stem Cell Engineering, Gene Therapy Development, Delivery System for Genetic Modifications | Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging |
| Target Customers | ||
| Target Customers | Patients with Hematologic Disorders, Healthcare Providers, Pharmaceutical Researchers, Biotech Investors | Patients with immune-mediated diseases, Individuals with immunodeficiencies, Patients experiencing age-related immune decline, Healthcare professionals seeking innovative treatments |
| Taxonomy | ||
| Taxonomy | Genomic MedicineIn Vivo TreatmentsGene ModificationImmune Cell EngineeringBlood Cell EngineeringEngenious Vectors +8 | Thymic Cell TherapiesIPSC ManufacturingImmunotherapyImmune RestorationAgingDisease Treatment +7 |
| Website | ||
| Website | ensoma.com | thymmune.com |
About Ensoma
Ensoma, established in 2019, is pioneering a transformative approach in the Biotechnology, Health and Wellness, and Life Sciences sectors. Operating from the United States, Ensoma focuses on developing one-time in vivo treatments that aim to precisely engineer blood and immune cells to combat diseas...
About Thymmune Therapeutics
Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to p...
Also comparing in this category
Comparing more than these two?
Get Ensoma, Thymmune Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Ensoma compare?
A PDF of Ensoma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Ensoma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Ensoma on 9 Jun 2026, and Thymmune Therapeutics on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
